Study guide

26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity

Key Takeaways Explain This Topic AI

Birth weight doubles at about 4 to 5 months and triples at 12 months; birth length doubles by about 4 years; the anterior fontanelle closes at 9 to 18 months.

Red flags include no social smile by 3 months, no sitting by 9 months, no walking by 18 months, no words by 16 months, no two-word phrases by 24 months, and any loss of skills at any age.

Autism spectrum disorder causes persistent deficits in social communication with restricted, repetitive behaviors; screen at 18 and 24 months, for example with the M-CHAT.

Exclusive breastfeeding is recommended for 6 months, then complementary foods with continued breastfeeding to 2 years or beyond (EO 51, RA 7600, RA 10028).

Severe acute malnutrition is weight-for-height below -3 SD, MUAC below 115 mm or bilateral pitting edema; F-75 is started cautiously and iron is withheld during stabilization.

Last updated: October 2026

Why this area matters

The TOS growth, development and nutrition competencies are to:

  • identify normal growth and development, and the red flag signs of delay;
  • recognize speech delay, autism, hyperactivity and attention deficit disorders and global developmental delay ;
  • calculate minimum daily nutrient requirements and recognize deficiencies;
  • address obesity and specific nutrient and vitamin deficiencies;

apply well-child and preventive care.

The Philippines carries a double burden of malnutrition . Stunting and wasting remain common, especially in poor and disaster-prone areas, while overweight and obesity are rising in school-age children and adolescents. The first 1,000 days, from conception to age 2, are the main window for prevention (RA 11148).

  • Normal Physical Growth Parameters and Trajectories
  • Body Weight Trajectory

Normal Birth Weight: 2,500 to 4,000 g (mean: 3,000 g).

Physiologic Weight Loss: Neonates normally lose up to 5% to 10% of birth weight during the first 3 to 5 days of life due to physiologic diuresis of extracellular fluid and initial low colostrum intake. Term infants should regain their original birth weight by day 10 to 14 .

Weight Doubling: Birth weight doubles at 4 to 5 months of age.

Weight Tripling: Birth weight triples at 12 months (1 year) of age.

Weight Quadrupling: Birth weight quadruples at 24 months (2 years) of age.

Rapid Clinical Weight Estimation Formulas (Weech's Formulas)

Age 3 to 12 months: Weight (kg) = Age (months) + 9 2 \text{Age 3 to 12 months: } \text{Weight (kg)} = \frac{\text{Age (months)} + 9}{2} Age 3 to 12 months: Weight (kg) = 2 Age (months) + 9 ​ Age 1 to 6 years: Weight (kg) = ( 2 × Age in years ) + 8 \text{Age 1 to 6 years: } \text{Weight (kg)} = (2 \times \text{Age in years}) + 8 Age 1 to 6 years: Weight (kg) = ( 2 × Age in years ) + 8 Age 7 to 12 years: Weight (kg) = ( 7 × Age in years ) − 5 2 \text{Age 7 to 12 years: } \text{Weight (kg)} = \frac{(7 \times \text{Age in years}) - 5}{2} Age 7 to 12 years: Weight (kg) = 2 ( 7 × Age in years ) − 5 ​

Length and Stature (Height)

Birth Length: Approximately 50 cm (20 inches).

First Year Increment: Increases by 25 cm (50% increase) to reach 75 cm at 12 months .

Doubling of Length: Birth length doubles at 4 years (100 cm).

Tripling of Length: Birth length triples at 13 years (150 cm).

Height Estimation Formula (Ages 2 to 12 Years)

Height (cm) = ( 6 × Age in years ) + 77 \text{Height (cm)} = (6 \times \text{Age in years}) + 77 Height (cm) = ( 6 × Age in years ) + 77

Head Circumference (Occipitofrontal Circumference - OFC)

Mean Birth OFC: Approximately 35 cm (exceeds chest circumference by 2 cm at birth; head and chest circumferences equalize at 12 months of age).

Rate of OFC Growth:

First 3 months: increases by 2.0 cm/month 2.0\text{ cm/month} 2.0 cm/month (reaches 41 cm at 3 months).

Months 4 to 6: increases by 1.0 cm/month 1.0\text{ cm/month} 1.0 cm/month (reaches 44 cm at 6 months).

Months 7 to 12: increases by 0.5 cm/month 0.5\text{ cm/month} 0.5 cm/month (reaches 47 cm at 12 months).

Fontanelle Closure Dynamics

Anterior Fontanelle: Diamond-shaped junction of the coronal, sagittal, and frontal sutures. Measures 2 × 2 cm 2 \times 2\text{ cm} 2 × 2 cm at birth. Normal physiologic closure occurs between 9 and 18 months .

Delayed closure: Seen in rickets, congenital hypothyroidism, hydrocephalus, trisomy 21 (Down syndrome), and achondroplasia.

Bulging fontanelle: Indicates elevated intracranial pressure (meningitis, intracranial hemorrhage, encephalitis).

Depressed (sunken) fontanelle: Clinical hallmark of dehydration.

Posterior Fontanelle: Triangular junction of the sagittal and lambdoid sutures. Normal physiologic closure occurs by 6 to 8 weeks (2 months) of age. Closure after 3 months warrants screening for congenital hypothyroidism.

Chronological Developmental Milestones Across Four Domains

Development proceeds in an orderly, cephalocaudal (head-to-toe) and proximodistal (center-to-periphery) direction. Milestones are systematically categorized into four functional domains: Gross Motor, Fine Motor / Adaptive, Language / Hearing, and Personal / Social.

Comprehensive Milestone Matrix (2 Months to 5 Years)

Age Gross Motor Domain Fine Motor / Adaptive Domain Language / Communication Domain Personal / Social Domain

2 Months Lifts head and chest 45° off bed when prone; steady head hold momentarily. Hands open 50% of time; tracks moving objects past midline (180°). Coos and vocalizes reciprocal musical vowel sounds ( aah , ooh ); alerts to sounds. Social smile (smiles responsively to human faces and voices).

4 Months Rolls from prone to supine (front to back); no head lag when pulled to sit. Reaches for objects with both hands; grasps rattle; hands brought together in midline. Laughs aloud; turns head toward sound of voice; squeals with delight. Enjoys looking around environment; initiates social interactions.

6 Months Sits unsupported (tripod sitting); rolls from supine to prone (back to front). Transfers objects hand-to-hand across midline; raking palmar grasp. Babbles consonant-vowel combinations ( ba-ba , da-da non-specifically). Stranger anxiety begins; feeds self crackers; recognizes familiar faces.

9 Months Crawls / creeps on all fours; pulls to a stand ; cruises along furniture. Immature (radial-digital) pincer grasp ; bangs two blocks together. Understands 'no'; responds to own name; waves bye-bye . Plays peek-a-boo ; develops object permanence (searches for hidden object).

12 Months Walks independently or with one hand held; stands alone securely. Mature (neat) two-finger pincer grasp ; releases cube into a cup voluntarily. Speaks first true word beyond mama/dada; follows simple one-step command with gesture. Drinks from cup held by caregiver; imitates household activities.

18 Months Runs stiffly; walks backward; climbs into adult chair; throws ball underhand. Builds tower of 3 to 4 cubes ; scribbles spontaneously; turns 2-3 pages at a time. Vocabulary of 10 to 25 words; identifies 1 or more body parts. Feeds self with spoon (spilling some); removes simple clothing (shoes, socks).

2 Years Kicks a ball forward; jumps with both feet; climbs stairs two feet per step . Builds tower of 6 cubes ; copies vertical line ; turns doorknobs. Uses 2-word phrases ( want milk ); 50+ word vocabulary; 50% speech intelligible to strangers. Parallel play (plays alongside peers); washes and dries hands with help.

3 Years Rides a tricycle ; climbs stairs alternating feet going up; stands on one foot 3s. Builds tower of 9 cubes ; copies a circle ; uses scissors to cut paper. Uses 3-word sentences ; uses pronouns ( I , you ); 75% speech intelligible to strangers. Group (associative) play; knows full name and sex; dresses with assistance.

4 Years Hops on one foot ; throws ball overhand; skips clumsily. Copies a cross (+) and square; draws a person with 3 body parts. Tells stories; understands prepositions ( under , on ); 100% speech intelligible to strangers. Cooperative play; imaginative/fantasy role-play; dresses independently except buttons.

5 Years Skips alternating feet ; jumps rope; stands on one foot for > 10 seconds > 10\text{ seconds} > 10 seconds . Copies a triangle ; ties shoelaces; prints simple letters; draws 6-part person. Fluent sentences; knows 4 colors; counts to 10; asks meanings of words. Follows rules in competitive games; fully independent in personal toileting.

  • High-Yield Shape Copying Progression for Board Exams
  • Age 3 Years: Circle ◯ \bigcirc ◯
  • Age 4 Years: Cross + + + and Square □ \square □
  • Age 5 Years: Triangle △ \triangle △
  • Age 6 Years: Diamond ♢ \diamondsuit ♢
  • Developmental red flags and disorders
  • Age Red flag
  • 2 to 3 months No social smile, no response to sounds, poor head control
  • 6 months No reaching for objects, persistent primitive reflexes, no babbling
  • 9 months Not sitting, no babbling with consonants, no response to name
  • 12 months No pointing or gestures, not pulling to stand
  • 16 to 18 months No single words by 16 months , not walking by 18 months
  • 24 months No two-word phrases

Any age Loss of previously acquired speech or social skills (regression), asymmetric movement or persistent hand preference before 12 months

Speech and language delay:

Always test hearing first , with otoacoustic emissions or an audiogram.

Distinguish expressive delay from receptive delay; receptive delay is more concerning.

Look for autism, intellectual disability, oral-motor problems and lack of stimulation (heavy screen exposure).

Refer early for speech therapy.

Autism spectrum disorder (ASD):

persistent deficits in social communication and interaction (poor eye contact, no joint attention, no pointing to share interest, lack of pretend play);

restricted, repetitive behaviors and interests (hand flapping, lining up toys, insistence on sameness, sensory sensitivities);

  • onset in early childhood, more common in boys;
  • screen at 18 and 24 months with a tool such as the M-CHAT-R/F ;

management is early intensive behavioral and developmental intervention, speech and occupational therapy, and parent training. Medication only treats associated symptoms such as irritability.

Attention-deficit/hyperactivity disorder (ADHD):

persistent inattention and/or hyperactivity-impulsivity , with symptoms before age 12 , present in 2 or more settings (home and school), impairing function;

management is behavioral therapy and parent training first in preschool children;

stimulants (methylphenidate) with school support for school-age children, with monitoring of appetite, growth, sleep, heart rate and BP.

Global developmental delay:

significant delay in 2 or more domains in a child under 5;

causes include genetic syndromes (Down, fragile X), perinatal asphyxia, congenital infections, hypothyroidism, inborn errors and severe deprivation;

evaluation covers hearing and vision, thyroid function, chromosomal microarray and fragile X testing, metabolic studies and neuroimaging as indicated.

Cerebral palsy is discussed with CNS disorders.

  • Pediatric Nutritional Requirements and Feeding Guidelines
  • Exclusive Breastfeeding: Legal Mandates and Clinical Standards

Under Philippine law—specifically Executive Order No. 51 (The Philippine Milk Code) , Republic Act No. 7600 (The Rooming-In and Breastfeeding Act of 1992) , and Republic Act No. 10028 (The Expanded Breastfeeding Promotion Act of 2009) —the promotion, protection, and support of breastfeeding is a national public health priority.

Exclusive Breastfeeding Duration: The DOH and WHO mandate exclusive breastfeeding for the first 6 months (180 days) of life. No water, teas, herbal concoctions, juices, or infant formula should be administered unless clinically indicated.

Continued Breastfeeding: Breastfeeding should continue alongside safe, adequate complementary foods for up to 2 years of age and beyond .

Comparative Composition of Human Milk vs. Cow's Milk

Nutrient Component Human Breast Milk Cow's Milk (Unmodified) Clinical Significance

Total Protein Low ( 0.9 − 1.1 g/dL 0.9-1.1\text{ g/dL} 0.9 − 1.1 g/dL ) High ( 3.3 − 3.5 g/dL 3.3-3.5\text{ g/dL} 3.3 − 3.5 g/dL ) Low protein protects immature neonatal kidneys from high renal solute load.

Whey-to-Casein Ratio 60:40 (predominantly whey) 20:80 (predominantly casein) Whey forms soft, easily digestible curds and empties rapidly from the stomach.

Predominant Whey Protein Alpha-lactalbumin, lactoferrin, sIgA Beta-lactoglobulin Beta-lactoglobulin in cow's milk is highly allergenic in human infants.

Carbohydrate (Lactose) High ( 7.0 g/dL 7.0\text{ g/dL} 7.0 g/dL ) Lower ( 4.8 g/dL 4.8\text{ g/dL} 4.8 g/dL ) High lactose promotes brain galactolipid synthesis and acidifies gut flora.

Fat Composition High in LC-PUFAs (DHA, ARA) Lacks essential DHA and ARA Essential for neonatal retinal maturation and central nervous myelination.

Iron Bioavailability 50% absorbed 10% absorbed Lactoferrin facilitates high absorption despite lower total elemental concentration.

Micronutrient Supplementation in Infancy

Vitamin D: Breast milk contains low concentrations of Vitamin D ( < 50 IU/L < 50\text{ IU/L} < 50 IU/L ). Exclusively breastfed infants should receive 400 IU/day of Vitamin D drops starting shortly after birth unless exposed to adequate sunlight.

Iron: Exclusively breastfed term infants have adequate fetal iron stores for 4 to 6 months. Begin elemental iron supplementation at 1 mg/kg/day at 4 months of age until iron-rich complementary foods (pureed meats, iron-fortified cereals) are well established. Preterm infants require 2 mg/kg/day starting at 1 to 2 months .

Complementary Feeding: Introduced at exactly 6 months (180 days) of age because nutritional requirements for energy, iron, zinc, and Vitamin A exceed breast milk supply alone.

  • Micronutrient Deficiency Syndromes
  • Vitamin D Deficiency (Nutritional Rickets)

Pathophysiology: Inadequate Vitamin D leads to impaired intestinal absorption of calcium and phosphorus, stimulating secondary hyperparathyroidism. Excess parathyroid hormone (PTH) causes renal phosphate wasting, leading to defective mineralization of bone matrix and unmineralized osteoid accumulation at growing epiphyseal growth plates.

Clinical Manifestations:

Craniotabes: Softening of the cranial bones yielding a 'ping-pong ball' sensation on pressing the parietal or occipital bones; it can be physiologic near the sutures in newborns, but beyond the first few months it suggests rickets.

Rachitic Rosary: Prominent, symmetrical nodular enlargement of the costochondral junctions.

Harrison Groove: Horizontal groove along the lower border of the thorax corresponding to the diaphragmatic insertion.

Skeletal Deformities: Delayed closure of anterior fontanelle, caput quadratum (frontal bossing), widened wrists and ankles, genu varum (bow legs) or genu valgum (knock knees).

Radiographic Findings: Widening of epiphyseal growth plate, cupping, fraying, and splaying of the metaphysis (best seen on bilateral wrist and knee radiographs).

Laboratory Profile: Serum calcium is low or normal; serum phosphorus is low; alkaline phosphatase (ALP) is markedly elevated ; serum PTH is elevated; 25-hydroxyvitamin D [25(OH)D] is < 20 ng/mL < 20\text{ ng/mL} < 20 ng/mL .

Vitamin A Deficiency (Xerophthalmia)

Leading cause of preventable childhood blindness worldwide.

WHO Clinical Staging of Xerophthalmia:

XN: Night blindness (nyctalopia) — earliest functional clinical sign.

X1A: Conjunctival xerosis (dryness, loss of luster).

X1B: Bitot's spots — pathognomonic foamy, triangular, silvery-white plaques on the temporal bulbar conjunctiva composed of keratinized epithelial debris.

X2: Corneal xerosis (hazy, dry cornea).

X3A / X3B: Corneal ulceration / keratomalacia involving < 1 / 3 < 1/3 < 1/3 (X3A) or > 1 / 3 > 1/3 > 1/3 (X3B) of corneal surface; irreversible full-thickness melting.

XS: Corneal scar.

XF: Xerophthalmic fundus.

Treatment Protocol: High-potency oral Vitamin A given on Day 1, Day 2, and Day 14 (50,000 IU for < 6 < 6 < 6 months; 100,000 IU for 6 to 11 months; 200,000 IU for ≥ 12 \ge 12 ≥ 12 months).

Iron Deficiency Anemia (IDA)

Etiology: Excessive cow's milk ingestion ( > 24 oz/day > 24\text{ oz/day} > 24 oz/day in toddlers), delayed introduction of solids, or chronic blood loss.

Laboratory Hallmarks: Microcytic, hypochromic anemia (low MCV, low MCH), low serum ferritin ( < 12 ng/mL < 12\text{ ng/mL} < 12 ng/mL ) , elevated Total Iron Binding Capacity (TIBC), transferrin saturation < 16 % < 16\% < 16% , elevated Free Erythrocyte Protoporphyrin (FEP), and elevated Red Cell Distribution Width (RDW > 15 % > 15\% > 15% , differentiating IDA from Thalassemia minor).

Treatment: Elemental iron at 3 to 6 mg/kg/day in 2 to 3 divided doses administered between meals with Vitamin C (ascorbic acid) to enhance absorption. Continue therapy for 2 to 3 months after hemoglobin normalizes to replenish bone marrow iron stores.

Severe Acute Malnutrition (SAM): Marasmus vs. Kwashiorkor

Severe Acute Malnutrition in children aged 6 to 59 months is defined by the WHO and DOH as:

  • Weight-for-height Z-score (WHZ) < − 3 < -3 < − 3 standard deviations , OR
  • Mid-Upper Arm Circumference (MUAC) < 115 mm < 115\text{ mm} < 115 mm (11.5 cm) , OR

Presence of bilateral nutritional pitting edema .

Pathophysiologic and Clinical Differentiation

Clinical Feature Marasmus (Non-Edematous SAM) Kwashiorkor (Edematous SAM)

Primary Nutritional Deficit Severe balanced caloric (energy) deprivation. Severe protein deficiency with marginal/adequate carbohydrates.

Nutritional Edema Absent . Present : bilateral pitting edema of feet, legs, hands, and face.

Subcutaneous Fat & Muscle Severe, profound generalized wasting; skin hangs in loose folds; ribs prominent. Muscle wasting often masked by generalized fluid retention and edema.

Facial Appearance 'Old man' or 'monkey' facies due to loss of buccal fat pads. 'Moon facies' (swollen, rounded, edematous cheeks).

Dermatologic Findings Dry, thin, wrinkled skin; no ulcerations. Flaky-paint dermatosis (crazy-paving hyperkeratotic patches that peel).

Hair Changes Normal or mild thinning. Dry, sparse, depigmented hair with alternating light/dark bands ( flag sign ).

Hepatic Pathology Normal liver size; no steatosis. Hepatomegaly due to diffuse fatty infiltration (apolipoprotein synthesis failure).

Mental State & Appetite Alert, irritable, but voraciously hungry. Marked apathy, lethargy, misery, and severe anorexia .

The WHO 10-Step Inpatient Stabilization Protocol for SAM

Children with complicated SAM must be admitted and managed according to the WHO 10-Step protocol divided into three phases: Stabilization (Days 1 to 7) , Rehabilitation (Weeks 2 to 6) , and Follow-up .

Step Clinical Target Stabilization Phase (Days 1 to 7) Protocol Rehabilitation Phase (Weeks 2 to 6)

1 Hypoglycemia Screen blood glucose ( < 54 mg/dL < 54\text{ mg/dL} < 54 mg/dL or 3.0 mmol/L 3.0\text{ mmol/L} 3.0 mmol/L ). Treat immediately with 50 mL of 10% dextrose PO or IV; feed every 2 hours day and night. Routine feeding schedule.

2 Hypothermia Core temp < 35.5 ∘ C < 35.5^\circ\text{C} < 35. 5 ∘ C . Keep child warm, Kangaroo Mother Care, maintain room temp > 25 ∘ C > 25^\circ\text{C} > 2 5 ∘ C . Prevent chilling.

3 Dehydration CRITICAL: avoid IV fluids except for shock, because they easily cause heart failure; give a slow, measured IV infusion only for shock. Rehydrate orally or by nasogastric tube with ReSoMal ( 5 mL/kg 5\text{ mL/kg} 5 mL/kg every 30 min for 2h, then 5 − 10 mL/kg/h 5-10\text{ mL/kg/h} 5 − 10 mL/kg/h for 4-10h). Continue hydration PRN.

4 Electrolytes All have excess total body sodium but severe cellular potassium and magnesium depletion. Add extra potassium ( 3 − 4 mmol/kg/day 3-4\text{ mmol/kg/day} 3 − 4 mmol/kg/day ) and magnesium ( 0.4 − 0.6 mmol/kg/day 0.4-0.6\text{ mmol/kg/day} 0.4 − 0.6 mmol/kg/day ). Do NOT add salt. Maintain electrolyte balance.

5 Infections Assume occult systemic bacteremia. Give broad-spectrum parenteral antibiotics: Ampicillin ( 50 mg/kg 50\text{ mg/kg} 50 mg/kg IV/IM q6h) + Gentamicin ( 7.5 mg/kg 7.5\text{ mg/kg} 7.5 mg/kg IV/IM once daily) for 7 days. Treat specific infections.

6 Micronutrients High-dose Vitamin A, zinc ( 2 mg/kg/day 2\text{ mg/kg/day} 2 mg/kg/day ), copper, and folic acid ( 5 mg 5\text{ mg} 5 mg on day 1, then 1 mg/day 1\text{ mg/day} 1 mg/day ). STRICTLY WITHHOLD IRON during stabilization. Add Elemental Iron ( 3 mg/kg/day 3\text{ mg/kg/day} 3 mg/kg/day ) once appetite returns and edema clears.

7 Cautious Feeding Initiate F-75 starter formula ( 75 kcal 75\text{ kcal} 75 kcal and 0.9 g protein 0.9\text{ g protein} 0.9 g protein per 100 mL 100\text{ mL} 100 mL ; 100 mL/kg/day 100\text{ mL/kg/day} 100 mL/kg/day in 8 to 12 feeds). Low protein and sodium prevent refeeding syndrome. Transition to catch-up feeding.

8 Catch-up Growth Transition from F-75 to F-100 catch-up formula ( 100 kcal 100\text{ kcal} 100 kcal and 2.9 g protein 2.9\text{ g protein} 2.9 g protein per 100 mL 100\text{ mL} 100 mL ) or Ready-to-Use Therapeutic Food (RUTF) once appetite returns. Vigorous feeding ( 150 − 220 kcal/kg/day 150-220\text{ kcal/kg/day} 150 − 220 kcal/kg/day ). Target weight gain > 10 g/kg/day > 10\text{ g/kg/day} > 10 g/kg/day .

9 Sensory Stimulation Provide loving care, maternal cuddling, colorful toys, and structured play therapy to stimulate cognitive recovery. Active child developmental stimulation.

10 Discharge Prep Educate parents on appropriate feeding, food hygiene, immunization completion, and early recognition of relapse. Community follow-up at 1, 2, 4 weeks.

Complementary feeding, obesity and Philippine nutrition programs

Complementary feeding from 6 months:

  • feed on demand with responsive feeding;
  • increase meal frequency and texture with age;
  • give iron-rich foods (meat, liver, fish, egg, fortified foods) and fruits and vegetables;
  • avoid sugary drinks and salty snacks;

give no honey before 12 months (infant botulism).

Cow's milk is not given as the main drink before 12 months.

Overweight and obesity:

Definitions (WHO growth references): BMI-for-age above +1 SD (overweight) or above +2 SD (obese) for children aged 5 to 19. Under 5, weight-for-length or BMI above +2 SD is overweight and above +3 SD is obese.

Complications: insulin resistance and type 2 diabetes, hypertension, fatty liver, sleep apnea, slipped capital femoral epiphysis, Blount disease and psychosocial problems.

Management: family-based lifestyle change (diet, physical activity, sleep and less screen time). Look for endocrine or genetic causes only if there is short stature or developmental delay.

Philippine programs:

Operation Timbang Plus : annual weighing and measuring of preschool children by barangays, used to target interventions;

  • vitamin A supplementation every 6 months for children aged 6 to 59 months;
  • micronutrient powders and iron supplementation;
  • salt iodization (RA 8172) and food fortification;
  • community-based management of acute malnutrition with ready-to-use therapeutic food;

the school-based feeding program (RA 11037).

Loading diagram... Severe Acute Malnutrition (SAM) Diagnostic and Phased Management Pathway